Diabetes is a group of metabolic diseases characterized by hyperglycemia. HYPERGLYCEMIA is caused by defective insulin secretion or impaired biological function, or both. The long-term existence of high blood sugar in diabetes leads to chronic damage and dysfunction of various tissues, especially eyes, kidneys, heart, blood vessels and nerves.Diabetes care drugs are used to treat diabetes.
This report contains market size and forecasts of Diabetes Care Drugs in Global, including the following market information:
- Global Diabetes Care Drugs Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global top five companies in 2021 (%)
The global Diabetes Care Drugs market was valued at 67200 million in 2021 and is projected to reach US$ 95620 million by 2028, at a CAGR of 5.2% during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Oral Anti-diabetic Drugs Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Diabetes Care Drugs include Novo Nordisk, Sanofi, Eli Lilly, Biocon, AstraZeneca, Bristol Myers Squibb, Boehringer Ingelheim, Mylan and Pfizer, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
We surveyed the Diabetes Care Drugs companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Diabetes Care Drugs Market, by Type, 2017-2022, 2023-2028 ($ millions)
Global Diabetes Care Drugs Market Segment Percentages, by Type, 2021 (%)
- Oral Anti-diabetic Drugs
- Insulins
- Non-insulin Injectable Drugs
- Other
Global Diabetes Care Drugs Market, by Application, 2017-2022, 2023-2028 ($ millions)
Global Diabetes Care Drugs Market Segment Percentages, by Application, 2021 (%)
- Hospital
- Medical Research Institute
- Clinic
- Other
Global Diabetes Care Drugs Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)
Global Diabetes Care Drugs Market Segment Percentages, By Region and Country, 2021 (%)
- North America
- US
- Canada
- Mexico
- Europe
- Germany
- France
- U.K.
- Italy
- Russia
- Nordic Countries
- Benelux
- Rest of Europe
- Asia
- China
- Japan
- South Korea
- Southeast Asia
- India
- Rest of Asia
- South America
- Brazil
- Argentina
- Rest of South America
- Middle East & Africa
- Turkey
- Israel
- Saudi Arabia
- UAE
- Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
- Key companies Diabetes Care Drugs revenues in global market, 2017-2022 (estimated), ($ millions)
- Key companies Diabetes Care Drugs revenues share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
- Novo Nordisk
- Sanofi
- Eli Lilly
- Biocon
- AstraZeneca
- Bristol Myers Squibb
- Boehringer Ingelheim
- Mylan
- Pfizer
- Johnson & Johnson
- Merck
- Novartis
- Astellas
- Teva
